ACE2 and COVID-19: Despite limited homology to the SARS-CoV-2 S and utilization of bat ACE2, BtKY72 S-mediated viral entry was efficiently neutralized by sera from COVID-19 vaccinated individuals (Fig. 5a and Supplementary Fig. 8).